Recently, it has also been reported that the knockout of ATF4 can reduce the resistance of gastric cancer cells to cisplatin or increase the sensitivity of BRAF-mutated melanoma to vemurafenib [35, 36]. This evidence concerns the gene BRAF and melanoma.